ABVC BioPharma (ABVC) Earnings Analysis

ABVC BioPharma (ABVC) has no confirmed upcoming earnings date. Trailing P/E -10.27.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ABVC next report earnings?

No confirmed upcoming earnings date is currently scheduled for ABVC. This page updates as the calendar is published.

ABVC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-18-0.06 USDn/an/an/a
2026-03-03-0.12 USDn/an/an/a
2025-10-31-0.05 USDn/an/an/a
2025-08-13-0.13 USDn/an/an/a
2025-04-30-0.06 USDn/an/an/a
2025-04-150.04 USDn/an/an/a
2024-11-14-0.02 USDn/an/an/a
2024-08-14-0.09 USDn/an/an/a

ABVC valuation and analyst view

Trailing P/E-10.27
Trailing EPS-0.37026 USD
Price / book2.79
Dividend yield0.00%
Market cap0.02B
Analyst consensusHold (0 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is ABVC BioPharma (ABVC)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for ABVC. This page updates as the calendar is published.

Did ABVC beat earnings last quarter?

Consensus estimate data was not available for ABVC's 2026-05-18 report.

What is ABVC's current P/E ratio and EPS?

ABVC trades at a trailing P/E of -10.27 on trailing EPS of -0.37026406569247494 USD.

What do analysts rate ABVC?

Analyst consensus is "Hold" across 1 ratings (0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell).